The 20 Best Stocks For 2016

Advertisement

7. Ligand Pharmaceuticals Inc. (LGND)

Ligand-Pharmaceuticals
[sc-ad-insert] Expected Yields: N/A

Growth Earnings: 4.0%

Having established a unique niche in the pharmaceuticals industry, this up-and-comer biotechnology company looks poised for big things, with over 125 programs under developmental license with over 72 drug companies, including big names such as Pfizer, Merck, and Amgen.

PeeJay
Advertisement

Pages: « »

Advertisement